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ABSTRACT
Background Renal replacement therapy rates are inversely related to socioeconomic status (SES) in developed countries. The relationship between
chronic kidney disease (CKD) and SES is less clear. This study examined the relationships between SES and CKD and albuminuria in England.
Methods Data from the Health Survey for England 2009 and 2010 were combined. The prevalence of CKD 3–5 and albuminuria was calculated,
and logistic regression used to determine their association with five individual-level measures and one area-level measure of SES.
Results The prevalence of CKD 3–5 was 5.2% and albuminuria 8.0%. Age–sex-adjusted CKD 3–5 was associated with lack of qualifications
[odds ratio (OR) 2.27 (95% confidence interval 1.40–3.69)], low income [OR 1.50 (1.02–2.21)] and renting tenure [OR 1.36 (1.01–1.84)].
Only tenure remained significant in fully adjusted models suggesting that co-variables were on the causal pathway. Albuminuria remained
associated with several SES measures on full adjustment: low income [OR 1.55 (1.14–2.11)], no vehicle [OR 1.38 (1.05–1.81)], renting [OR 1.31
[1.03–1.67)] and most deprived area-level quintile [OR 1.55 (1.07–2.25)].
Conclusions CKD 3–5 and albuminuria were associated with low SES using several measures. For albuminuria this was not explained by known
measured causal factors.
Keywords chronic kidney disease, epidemiology, socioeconomic factors
Background
Chronic kidney disease (CKD) is a global public health
problem with the prevalence of CKD stage 1–5 of 10–16%
in adults.1–4 CKD is deﬁned and staged by level of kidney
function (estimated glomerular ﬁltration rate, eGFR) and the
presence of markers of kidney damage (most commonly albu-
minuria).5 Both eGFR and albuminuria are strong independ-
ent risk factors for all-cause and cardiovascular disease
(CVD) mortality;6,7 progression to end-stage renal disease
(ESRD);8 need for renal replacement therapy (RRT, dialysis
and renal transplant) and acute kidney injury.8
Understanding inequalities in CKD is important in guiding
strategies for prevention, detection and intervention. There is
an inverse relationship between RRT rates and socioeconomic
status (SES) in the UK and in other countries, whether using
area-level deprivation measures as a proxy for individual
status9–14 or individual socioeconomic measures.15 The rela-
tionship between CKD and SES is less clear. Nationally repre-
sentative surveys in some (but not all) developed countries
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(including those with and without national health services)
have shown variation in CKD prevalence by SES, both within
and between countries.16 Initial analysis of the 2009 and 2010
Health Surveys for England [HSEs, nationally representative
surveys similar to US National Health and Nutrition
Examination Surveys (NHANES)] showed mixed evidence
for variation of CKD prevalence by area-level deprivation
status, depending on severity of CKD.17,18 Data from
NHANES III demonstrated the association between microal-
buminuria and poverty,19 but no evidence is available in the
UK on the relationship between albuminuria and SES. The
association between low SES and increased risk of CKD diag-
nosis20 and increased severity of CKD at presentation to renal
services21 has been demonstrated in the UK. Any observed
variations in the CKD prevalence may be explained by differ-
ences in lifecourse exposures harmful to the kidney, such as
foetal environment, environmental toxins, tobacco, obesity,
hypertension and diabetes; and access to and use of health
services. However, consideration needs to be given to the dif-
ferent measures of SES used and limitations of area-level
proxies. This study aimed to provide detailed analysis of the
associations of several socioeconomic factors (using both area-
level and individual measures) with CKD stage 3–5, using the
Chronic Kidney Disease Epidemiology Collaboration (CKDEPI)
equation to estimate GFR, and with albuminuria in the 2009
and 2010 HSEs.22
Methods
Full details of HSE methods, measurement of non-CKD
variables and response rates are given in the HSE reports.17,18
A random, nationally representative sample was selected each
year using a stratiﬁed, two-stage sample of private addresses.
Participants completed an interview questionnaire; most con-
sented to a nurse visit. In the 2009 or 2010 HSE, a valid urine
sample was obtained from 88% of men and 86% of women
aged 16 and over who had a nurse visit, and a non-fasting
blood sample from 77% of men and 73% of women.
Approval was obtained from the Oxford B Research Ethics
Committee for both surveys (HSE 2009 ref 08/H0605/103,
HSE 2010 ref 09/H0605/73).
Socioeconomic factors selected included: (i) occupation using
National Statistics Socioeconomic Classiﬁcation23 [NS-SEC, in
three categories: high (managerial and professional occupa-
tions), middle (intermediate occupations) and low (routine and
manual occupations)]; (ii) qualiﬁcations grouped as: degree
(NVQ4/NVQ5/Degree or equivalent), below degree (higher
education below degree or NVQ3/GCE A Level equivalent or
NVQ2/GCE O Level equivalent or NVQ1/CSE other grade)
and none (no qualiﬁcation); (iii) household income tertiles; (iv)
household tenure (owned or rented accommodation); (v) access
to motor vehicle within the household (any versus none) and
(vi) area-level deprivation [using Index of Multiple Deprivation
2007 (IMD) national quintiles: 1 least deprived (IMD 0.37–
8.32), 2 (8.32–13.75), 3 (13.75–21.22), 4 (21.22–34.42) and 5
most deprived (34.42–85.46)].24
Ethnicity was self-deﬁned using 2001 census categories.
Hypertension was deﬁned as self-reported pre-existing doctor
diagnosis, survey-deﬁned [high blood pressure identiﬁed (BP
systolic 140 mmHg and/or diastolic 90 mmHg and/or
taking medication for hypertension) at survey examination]
and ‘total’ (doctor þ survey diagnosed). Diabetes was treated
similarly: survey-deﬁned diabetes was HBA1c 6.5% at clinic
visit. Body mass index (BMI) was classiﬁed as normal
(,25 kg/m2), overweight (25–29.9 kg/m2) and obese
(30 kg/m2).25 Waist circumference was classiﬁed as: ,94 cm,
94–102 cm (high) and .102 cm (very high) for men, and
,80 cm, 80–88 cm (high) and .88 cm (very high) for
women. For South Asians, the waist circumference threshold
was 90 cm (men) and 80 cm (women).25
Serum creatinine was assayed using an IDMS traceable en-
zymatic assay in a single laboratory [Clinical Biochemistry
Department at the Royal Victoria Inﬁrmary (RVI), Newcastle-
upon-Tyne]. Albuminuria was assessed using urinary albumin
creatinine ratio (ACR), measured on a single random urine
sample. Abnormal levels were divided into microalbuminuria
(ACR 2.5–30 mg/mmol in men and 3.5–30 mg/mmol in
women) and macroalbuminuria [ACR. 30 mg/mmol (in
either sex)].26 CKDEPI eGFR values were derived using the
standard equation,22 a more accurate measure of true eGFR
than the Modiﬁcation of Diet in Renal Disease (MDRD) equa-
tion in routine use in the UK.27 Details of laboratory analysis,
internal quality control and external quality assurance are pro-
vided in HSE documentation.17,18 The Kidney Disease: im-
proving Global Outcomes classiﬁcation of CKD based on
level of eGFR was used: Stage 1: eGFR 90 ml/min/1.73 m2
or more with albuminuria, Stage 2: 60–89 ml/min/1.73 m2
with albuminuria, Stage 3a: 45–59 ml/min/1.73 m2, Stage 3b:
30–44 ml/min/1.73 m2, Stage 4: 15–29 ml/min/1.73 m2 and
Stage 5: ,15 ml/min/1.73 m2.28 Current guidelines recom-
mend that CKD be deﬁned on the basis of reduced eGFR
present for at least 3 months.5,26,28 However, because of the
cross-sectional nature of the HSEs, a single eGFR ,60 ml/
min/1.73 m2 was used to deﬁne CKD stage 3–5 in these
analyses.
Statistical analyses
The prevalence by CKD stage included participants with
both serum creatinine and urinary ACR data. Analyses of











CKD and albuminuria associations used all participants with
relevant data to maximize power and to allow analysis of albu-
minuria individually. Logistic regression models were used to
examine the relationships between CKD and demographic,
socioeconomic, lifestyle and clinical factors, adjusted for age
and sex. Age was categorized as ,65 and 65. An age  sex
interaction term was included in multivariable regression
models following identiﬁcation of an age  sex interaction
for CKD 3–5 early in our analyses. Overall, CKD prevalence
estimation accounted for weighting within gender to allow for
gender differences in response. Non-response weights were
used in all analyses. Despite low numbers from ethnic minor-
ities, ethnicity is associated with variation in RRT rates,13,14
and ethnicity was therefore included as a potential confounder
in multivariable analyses. Three dichotomized-dependent
variables were investigated: CKD deﬁned by the CKDEPI
equation as eGFR ,60 ml/min/1.73 m2 (Stage 3–5); the
presence of micro- or macro-albuminuria and CKD stage
1–2 deﬁned as eGFR .60 ml/min/1.73 m2 with evidence
of albuminuria. Sensitivity analyses were conducted in the
white-only population, and, for albuminuria, in people without
diabetes. For CKD 3–5, analyses were also conducted using
the MDRD equation to deﬁne CKD.
Interactions of socioeconomic variables with age and sex
were examined and also with diabetes in the albuminuria
models. The ﬁnal models were (i) age, sex and age  sex, (ii)
age, sex, ethnicity and age  sex and (iii) age, sex, ethnicity,
age  sex, smoking, BMI, doctor diagnosed hypertension
and doctor diagnosed diabetes.
Odds ratios are presented with 95% conﬁdence intervals
(CIs) and P values of ,0.05 were considered statistically sig-
niﬁcant. All analyses, adjusted for the complex survey design,
were performed using IBM SPSS Statistics version 19.
Results
The total combined sample size (unweighted) for the 2009
and 2010 HSE was 13 065 individuals aged 16 and over.
Sample characteristics (weighted for non-response) are shown
in Table 1. In total, 5799 (44.4%) respondents had a valid
serum creatinine value, 7592 (58.1%) had a valid ACR and
5318 (40.7%) had both. Of the unweighted sample of 5799
individuals, 3186 (54.9%) were female (51.2% of the weighted
sample). Of those excluded because they lacked a valid serum
creatinine, 1994 (27.6%) had no formal qualiﬁcations (com-
pared with 20.6% in those included). Of those without valid
ACR, 1239 (22.4%) had no access to a motor vehicle and 1660
(30.2%) had no qualiﬁcations (compared with 16.7 and 20.3%
in those included). Otherwise those included and those
excluded were comparable with regard to SES.
The overall weighted prevalence of CKD stage 3–5 was
303/5786 (5.2%). The prevalence of any albuminuria was
8.2% in men and 7.5% in women [for macroalbuminuria, 0.3
and 0.5% respectively (only 22 people)]. Both CKD 3–5 and
albuminuria prevalence was higher in people with low income,
no access to a vehicle and no formal qualiﬁcations. Prevalence
patterns for CKD 1–2 and CKD 3–5 with albuminuria were
similar to those for overall albuminuria [although the number of
people with CKD stage 3–5 with albuminuria was low (n¼ 66)]
(Table 2).
Age–sex-adjusted CKD 3–5 was associated with lack of
qualiﬁcations [odds ratio (OR) 2.27 (95% CI 1.40–3.69)], low
income [OR 1.50 (1.02–2.21)] and renting household tenure[OR
1.36 (1.01–1.84) versus ownership]. Tenure remained signiﬁcant
in fully adjusted models. Albuminuria remained associated with
several SES measures on full adjustment: low income [OR 1.55
(1.14–2.11)], no vehicle [OR 1.38 (1.05–1.81)], renting [OR 1.31
(1.03–1.67)], most deprived area-level quintile [OR 1.55 (1.07–
2.25)] (Fig. 1 and Supplementary data, Appendix Table S1).
Table 3 shows the prevalence and associations for lifestyle
and clinical factors, which might act as confounding/explanatory
factors for the SES–CKD relationship. BMI, diabetes and
hypertension were positively associated with CKD and albu-
minuria, whereas total cholesterol was not associated with
either. HDL cholesterol was negatively associated with both.
All SES measures were associated with smoking, type 2 dia-
betes, hypertension and obesity after age–sex adjustment
(Supplementary data, Appendix Table S2). CKD 1–2 was
associated with smoking, BMI, waist circumference, HDL
cholesterol, diabetes and hypertension (data not shown).
A signiﬁcant age  sex interaction (P, 0.05) was identi-
ﬁed in the CKD models, with younger (,65) females having
greater odds of CKD compared with younger males but with
no difference in older age groups. There were no signiﬁcant
interactions between age and SES in the CKD models or dia-
betes and SES in the albuminuria models.
There were no differences in these results in the sensitivity
analyses for the white-only population, and, for albuminuria,
in people without diabetes (data not shown).
The use of the MDRD equation in place of CKDEPI
resulted in slightly different associations of CKD 3–5 with
SES, with qualiﬁcation level and vehicle ownership remaining
associated in the fully adjusted model (Supplementary data,
Appendix Table S3).
Discussion
Main findings of this study
This study found socioeconomic disparities in the prevalence
of CKD stage 3–5, using the CKD-EPI equation to deﬁne











Table 1. Sociodemographic and clinical characteristics of the weighted study sample
Variable Category People with valid serum
creatinine value
People with urine albumin
creatinine ratio value
Number Column % Number Column %
All Aged 16þ 5799 100 7592 100
Age 16–34 1756 30.3 1949 25.7
34–54 2037 35.1 2844 37.5
55–64 856 14.8 1218 16.0
65–74 615 10.6 871 11.5
75þ 522 9.0 655 8.6
Ethnicity White 5244 90.4 6884 90.7
South Asian 243 4.2 285 3.8
Black 154 2.7 200 2.6
Other 139 2.4 160 2.1
Sex Male 2823 48.7 3667 48.3
Female 2963 51.1 3870 51.0
Income tertile Lowest 1393 24.0 1517 20.0
Middle 1617 27.9 1963 25.9
Highest 1829 31.5 2224 29.3
Access to motor vehicle Yes 4728 81.5 6280 82.7
No 1056 18.2 1256 16.5
Qualification Degree 1295 22.3 1761 23.2
Below degree 3296 56.8 4238 55.8
None 1197 20.6 1531 20.2
Occupation (NS-SEC) High 1894 32.7 2646 34.9
Middle 1203 20.7 1611 21.2
Low 2619 45.2 3207 42.2
IMD Quintile 1. Least deprived 1197 20.6 1683 22.2
2. 1204 20.8 1601 21.1
3. 1228 21.2 1627 21.4
4. 1105 19.1 1442 19.0
5. Most deprived 1051 18.1 1184 15.6
Housing Tenure Own/mortgage 3955 68.2 5389 71.0
Rent/other 1817 31.3 2148 28.3
Smoking Never 3126 53.9 4089 53.9
Ex 1429 24.6 2007 26.4
Current 1210 20.9 1423 18.7
Body mass index (BMI) Normal 1956 33.7 2468 32.5
Overweight 2047 35.3 2683 35.3
Obese 1314 22.7 1815 23.9
Waist circumference Low 2120 36.6 2701 35.6
High 1347 23.2 1761 23.2
Very High 2242 38.7 2938 38.7
Total cholesterol ,5 mmol/l 2675 46.1 2984 39.3
5 mmol/l 3110 53.6 3719 49.0
HDL cholesterol ,1.2 mmol/l 1301 22.4 1591 21.0
1.2 mmol 4485 77.3 5809 76.5
Albuminuria None 4837 83.4 6896 90.8
Micro 399 6.9 601 7.9
Macro 22 0.4 39 0.5
Diabetes No diabetes 5370 92.6 6957 91.6
Doctor diagnoseda 305 5.3 450 5.9












Variable Category People with valid serum
creatinine value
People with urine albumin
creatinine ratio value
Number Column % Number Column %
Survey definedb 316 5.4 442 5.8
Totalc 429 7.4 581 7.7
Hypertension No HT 3800 65.5 4854 63.9
Doctor diagnoseda 1387 23.9 1992 26.2
Survey definedd 1542 26.6 2112 27.8
Totalc 1980 34.1 2683 35.3
Chronic kidney disease Yes 303 5.2 — —
No 5483 94.6 — —
aSelf-reported doctor diagnosis.
bHBA1c 6.5%.
cDoctor or survey diagnosed.
dIdentified as high blood pressure (BP systolic 140 mmHg and/or diastolic 90 mmHg and/or taking medication for hypertension).
Table 2. Directly age–sex standardized prevalence (%) of CKD stage 3–5 and albuminuria by sociodemographic characteristics














Weighted (n ¼ 66)
All Aged 16þ 5.2 8.0 7.1 1.1
Ethnicity White 5.6 8.1 7.2 1.3 5244
South Asian 1.1 6.4 6.3 0.2 243
Black 2.7 6.8 6.5 0.6 154
Other 0.7 6.2 6.2 0.1 137
Income tertile Lowest 6.5 8.7 7.5 1.5 1393
Middle 6.0 8.3 7.3 1.4 1617
Highest 3.0 6.9 6.5 0.6 1830
Access to motor
Vehicle
Yes 4.4 7.7 7.0 1.0 4729
No 8.6 9.2 7.7 2.0 1057
Qualification Degree 2.5 7.1 6.7 0.5 1295
Below degree 3.6 7.3 6.7 0.8 3297
None 12.4 10.8 8.9 2.9 1192
Occupation
(NS-SEC)
High 4.6 7.8 7.0 1.1 1894
Middle 6.1 8.0 7.1 1.3 1203
Low 5.7 8.2 7.3 1.3 2343
IMD quintile 1. (IMD 0.37–8.31)
Least deprived
6.0 8.2 7.3 1.4 1196
2. (IMD 8.32–13.74) 6.3 8.5 7.5 1.4 1204
3. (IMD 13.75–21.21) 4.8 7.8 7.0 1.1 1229
4. (IMD 21.22–34.41) 4.6 7.7 6.8 1.1 1105
5. (IMD 34.42–85.46)
Most deprived
3.9 7.5 6.8 0.9 1051
Housing tenure Own/mortgage 5.7 8.1 7.2 1.3 3956
Rent/other 3.9 7.6 6.9 0.9 1816











Low income (versus high)






Most deprived quintile of IMD (versus least)
No vehicle ownership (versus owning)
Renting (versus owning)
No qualification (versus degree)
Low occupation (versus high)
Low income (versus high)
Most deprived quintile of IMD (versus least)
No vehicle ownership (versus owning)
Renting (versus owning)
No qualification (versus degree)
Low occupation (versus high)
Fig. 1. Associations of CKD stage 3–5 and Albuminuria with measures of SES (age–sex and fully adjusted models). Open circle marker: age–sex adjusted.
Closed circle marker: fully adjusted model.











CKD, for individual measures of SES. It also identiﬁed socio-
economic disparities in the prevalence of albuminuria, an in-
dependent predictor of poor outcomes, for a wide range of
both individual and an area-level measures of SES.
Higher CKD 3–5 prevalence was associated with lack of
qualiﬁcations, low income and housing tenure (renting) after
adjusting for age and sex. These associations were not main-
tained after further adjustment for ethnicity, lifestyle and clin-
ical variables (obesity, diabetes, hypertension and smoking),
which are likely to be explanatory factors on the causal
pathway. Higher albuminuria prevalence was associated with
low income, lack of vehicle ownership, housing tenure
(renting) and IMD, and these were maintained, though attenu-
ated, after full adjustment, demonstrating independence from
these key factors on the causal pathway.
What is already known on this topic
Our results support the ﬁndings of several other studies.
A population-based case–control study in Sweden found an
approximately doubled adjusted odds ratio of having CKD in
families with only unskilled workers compared with families
with at least one professional (after adjusting for age, sex,
BMI, smoking, alcohol and aspirin or paracetamol use).29
A cross-sectional study in the UK of incident CKD present-
ing to renal services found increased risk of low eGFR
(,30 ml/min/1.73 m2) in areas with greater socioeconomic
deprivation.21 Cross-sectional data from the Whitehall II
cohort identiﬁed higher odds of low eGFR in lower occupa-
tional grades; this association was attenuated after adjustment
for BMI and components of the metabolic syndrome; similar
to our ﬁndings.30 The Atherosclerosis Risk in Communities
Table 3. Prevalence and age-/sex/age  sex-adjusted associations of CKD stage 3–5 and albuminuria (all albuminuria cases) with behavioural and clinical
factors
Variable Category CKD 3–5 Albuminuria
Prevalence (%) Odds ratio (95% CI) P value Prevalence (%) Odds ratio (95% CI) P value
Smoking Current 4.5 1 0.854 8.4 1 0.048
Ex 8.9 1.24 (0.80–1.92) 9.7 0.85 (0.63–1.15)
Never 2.4 1.02 (0.62–1.65) 6.9 0.76 (0.59–0.99)*
Body mass index (BMI) Normal 2.3 1 0.001 6.6 1 0.048
Overweight 5.0 1.72 (1.18–2.52) 6.7 1.11 (0.86–1.43)
Obese 7.5 2.75 (1.87–4.04) 8.4 1.33 (1.01–1.75)*
Waist circumference Low 2.1 1 ,0.001 6.4 1
High 5.5 1.57 (1.05–2.34) 7.7 1.10 (0.83–1.45) 0.636
Very High 7.9 1.97 (1.38–2.81) 9.2 1.27 (0.99–1.62) 0.051
Total cholesterol ,5 mmol/l 5.6 1 0.092 8.4 1
5 mmol/l 4.9 0.80 (0.62–1.04) 8.0 0.90 (0.73–1.09) 0.251
HDL cholesterol ,1.2 mmol/l 6.9 1 ,0.001 10.0 1
1.2 mmol 4.7 0.55 (0.41–0.74) 7.6 0.73 (0.58–0.93)** 0.003
Albuminuria None 4.6 1 ,0.001 — — —
Micro 16.0 2.34 (1.65–3.31) — —
Macro 30.0 7.53 (2.22–25.5) — —
Diabetes No diabetes 4.4 1 ,0.001 7.0 1 ,0.001
Doctor diagnoseda 15.5 3.83 (2.74–5.35) 22.9 2.69 (1.95–3.70)
Survey definedb 16.8 4.33 (3.14–5.99) 16.8 2.56 (1.93–3.41)
Totalc 15.4 3.99 (2.97–5.35) 20.4 2.50 (1.89–3.66)
Hypertension No hypertension 2.1 1 ,0.001 5.2 1 ,0.001
Doctor diagnoseda 13.1 5.56 (4.37–7.09) 14.4 2.25 (1.81–2.81)
Survey definedd 12.4 5.11 (3.99–6.56) 9.6 2.13 (1.69–2.69)




cDoctor or survey diagnosed.
dIdentified as high blood pressure (BP systolic 140 mmHg and/or diastolic 90 mmHg and/or taking medication for hypertension).











(ARIC) study identiﬁed an association of CKD incidence
with individual SES (occupation).31 White et al., comparing
ﬁndings from nationally representative surveys in the USA
and Australia, showed variation between countries, and, for
the USA, between different ethnic groups, in associations
between SES and CKD 3–5 prevalence.16 American
non-Hispanic Whites with lower levels of education or in the
lowest income quartile were more likely to have CKD com-
pared with those with higher education levels, employed
groups and those in the highest income quartile.16 In contrast,
an Australian national survey did not demonstrate an associ-
ation of CKD prevalence with SES (measured by education
and income) after age–sex adjustment.16 The recent Quality
Improvement in CKD trial in the UK identiﬁed the associa-
tions between deprivation (IMD) and CKD prevalence,
though this was not considered ‘clinically signiﬁcant’.32
Reasons for these variations are likely to be complex, but may
relate to differences in health-care systems or access to health
care and primary prevention.16
What this study adds
There is little existing evidence on the relationship between al-
buminuria and SES. Data from NHANES III demonstrated
the association between microalbuminuria and poverty in the
USA (adjusted OR 1.18, 1.05–1.33),19 and similar associa-
tions have been shown with various measures of SES in a
Malay population.33 To our knowledge, this is the ﬁrst study
to investigate the association between albuminuria and SES in
a representative population sample in the UK. In unadjusted
analyses, our data suggest socioeconomic inequalities in albu-
minuria distribution, both in those with eGFR ,60 ml/min/
1.73 m2 and those with eGFR above this level, which will in-
ﬂuence differential propensity to progress. There are few data
on the relationship between SES and CKD progression. The
(ARIC) study in the USA identiﬁed that, for white men, living
in the lowest compared with the highest SES area-level
quartile was associated with increased risk of CKD progres-
sion (hazard ratio for elevated serum creatinine 1.6 (95% CI
1.0–2.5).34 The reasons for ﬁnding association between SES
and CKD and albuminuria may be partly related to the social
distribution of underlying factors associated with CKD occur-
rence and progression,34 including obesity,35 smoking, type 2
diabetes36 and hypertension.37 Persistence of the association
for albuminuria after adjustment suggests other causal mech-
anisms (and or potential residual confounding) may apply.
Albuminuria is a key determinant of progression and poor
outcome in CKD, particularly when combined with other risk
factors (type 2 diabetes and hypertension), which are more
prevalent in lower socioeconomic groups. Other factors such
as low birth weight38 and health care access (with variation by
health system) also show socioeconomic patterns.39
Limitations of this study
Strengths of this study include the nationally representative
nature of the 2009 and 2010 HSE data, pooled over 2 years,
increasing numbers and precision of estimates, the rigorous
nature of HSE methodology with standardized protocols for
measurement by trained interviewers and nurses, all samples
being tested in the same laboratory with standardized assays,
use of non-response weighting to reduce response bias and
use of various SES measures.
The study was limited by its cross-sectional nature, redu-
cing the ability to infer causal relationships. Reverse causation
was, however, considered unlikely as the majority of people
with CKD are asymptomatic. Non-response weighting is an
effective method to avoid bias and maintain representative-
ness of the sample.40 An important limitation was using
single samples to test for serum creatinine and albuminuria.
Persistence of reduced eGFR levels and elevated ACR to
conﬁrm chronicity could not be shown, which could lead to
non-differential misclassiﬁcation. Our methods were similar
to those used in NHANES III, but repeat testing of ACR in
NHANES showed reduced albuminuria prevalence.2,19 The
use of single eGFR has also been shown to elevate CKD
prevalence estimates.41 Conﬁrmation in longitudinal studies
would therefore be beneﬁcial. There were too few cases from
minority ethnic groups to give robust data on ethnic differ-
ences in CKD prevalence. South Asians and Blacks have
higher rates of RRT42 but lower prevalence of CKD than
Caucasians.43 The prevalence of CKD stage 4–5 is likely to
be underestimated as, while the HSE adjusts for non-
response among the general population in private households,
it may not account for some in whom more severe CKD is
more common (people in residential care or those unable to
participate because of poor health or hospitalization) and may
therefore miss individuals with ESRD. Further limitations are
lack of data on prevalent CVD and family history, small
numbers with macroalbuminuria, lack of information on
medication use (differential use of renin angiotensin aldoster-
one system inhibitors by SES could result in less apparent al-
buminuria in those with higher SES). Accurately measuring
SES in elderly populations is challenging, and non-differential
misclassiﬁcation may bias associations towards the null.44
Survivor bias may have reduced socioeconomic gradients,
with competing risk of mortality from premature deaths in
poorer groups. Heterogeneity of our ﬁndings in terms of dif-
ferent measures of SES could be considered a limitation.
However, given the challenges of accurately measuring SES











using any single measure, we believe that the overlap in
associations shown here demonstrates support for true asso-
ciation rather than lack of it. A lifecourse approach to asses-
sing SES that is beyond the scope of this study would be
needed to fully understand the relationships between different
measures and may be an important consideration for future
research.39,45
Supplementary data
Supplementary data are available at the Journal of Public Health
online.
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